Theriva Biologics Inc TOVX:NYSE American

RT Quote | USD
Last | 05/20/24 EDT
0.37quote price arrow down-0.0007 (-0.1888%)
Volume
35,600
52 week range
0.20 - 1.20
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3707
  • 52 Week High1.20
  • 52 Week High Date06/28/23
  • 52 Week Low0.20
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap6.393M
  • Shares Out17.28M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-13.97

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3707
  • 52 Week High1.20
  • 52 Week High Date06/28/23
  • 52 Week Low0.20
  • 52 Week Low Date11/13/23
  • Market Cap6.393M
  • Shares Out17.28M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-13.97

RATIOS/PROFITABILITY

  • EPS (TTM)-1.15
  • P/E (TTM)-0.32
  • Fwd P/E (NTM)-0.31
  • EBITDA (TTM)-21.505M
  • ROE (TTM)-48.05%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.65%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Theriva Biologics Inc

 

Profile

MORE
Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. It is advancing a new oncolytic adenovirus platform. Its candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01 is an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and...
Jeffrey Kraws
Independent Chairman of the Board
Steven Shallcross
Chief Executive Officer, Chief Financial Officer, Director
Address
9605 Medical Center Drive, Suite 270
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
ADIL
Adial Pharmaceuticals Inc
1.50-0.05-3.25%
TENX
Tenax Therapeutics Inc
3.77+0.22+6.23%
CING
Cingulate Inc
0.7899-0.012-1.4963%
ATXI
Avenue Therapeutics Inc
3.81+0.08+2.14%
VIRI
Virios Therapeutics Inc
0.197-0.1544-43.9385%